GPT-Rosalind Brings Frontier AI to Drug Discovery
OpenAI’s GPT-Rosalind is a purpose-built reasoning model for life sciences — targeting drug discovery, genomics, and protein analysis. Here’s what it actually does.
OpenAI’s GPT-Rosalind is a purpose-built reasoning model for life sciences — targeting drug discovery, genomics, and protein analysis. Here’s what it actually does.
OpenAI’s updated Codex app for macOS and Windows adds computer use, in-app browsing, image generation, memory, and plugins. Here’s what that means for developers.
Google now offers prepay billing for the Gemini API in AI Studio. Here’s what it means for developers managing costs and scaling AI projects in 2026.
Google’s 2025 Ads Safety Report reveals how Gemini-powered tools blocked billions of harmful ads. Here’s what changed, what it means, and what’s still broken.
Google’s Nano Banana 2 update lets the Gemini app create personalized images using your life context and Google Photos. Here’s what it does and why it matters.
OpenAI expands its Trusted Access for Cyber program with GPT-5.4-Cyber, giving vetted security teams early access to its most capable cybersecurity AI model yet.
OpenAI’s Agents SDK update adds native sandbox execution and a model-native harness. Here’s what that means for developers building long-running AI agents.
Google’s Gemini 3.1 Flash TTS brings expressive, natural-sounding AI speech to products everywhere. Here’s what it does, how it works, and who wins.
Google’s Gemini app lands on macOS as a native desktop experience. Here’s what it does, how it stacks up against ChatGPT, and who it’s actually for.
Google DeepMind’s Gemini Robotics ER-1.6 upgrades robot reasoning to handle real-world tasks. Here’s what changed, why it matters, and who should care.
Cloudflare’s Agent Cloud now integrates OpenAI’s GPT-5 and Codex, letting enterprises build and scale AI agents faster. Here’s what it means for your business.
OpenAI’s Applications of AI course breaks down real-world uses of ChatGPT, Codex, and APIs. Here’s what it teaches and who should actually take it.